Michael P. Stehn

Corporate Officer/Principal bei Parenteral Drug Association

Health Technology

Consumer Services

Aktive Positionen von Michael P. Stehn

Unternehmen	Position	Beginn	Ende
Parenteral Drug Association	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
AKORN, INC.	Geschäftsführer	01.01.1990	05.09.2012
AKORN, INC.	Corporate Officer/Principal	05.09.2012	01.02.2020
The Rugby Group, Inc. The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million.	Corporate Officer/Principal	-	-

Fairleigh Dickinson University

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Chief Operating Officer	1
Undergraduate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
Akorn, Inc. Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL.	Health Technology
The Rugby Group, Inc. The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million.	Health Technology
Parenteral Drug Association